Clinical Trial Update: A Study to Investigate Aqueous Humor and Multimodal Imaging Biomarkers in Treatment-Naïve Participants With Diabetic Macular Edema Treated With Faricimab [Phase 2]

View source ↗

Summary

Phase 2 trial investigating faricimab in treatment-naïve diabetic macular edema with multimodal imaging biomarkers; study completed and results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Faricimab (faricimab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diabetic Macular Edema | Phase 2 | Status: COMPLETED | Results posted: 2023-12-01